Neurava develops wearable medical devices to monitor seizures in people with epilepsy.
Neurava develops wearable medical devices that monitor epilepsy-related signals and detect potential seizures, including at night, with alerts for caregivers. The device can transmit data to physicians to support treatment planning. Founded in 2019, the company is based in Indiana, US. In April 2024, it raised USD 2.26 million in seed funding led by Life Science Angels, with participation from UCB, Purdue Innovates, Elevate Ventures, Rivermount Ventures, and First Leaf Capital.
Funding rounds, investors and people for this company come from licensed data. A free account shows the first rows of each section; an approved contribution opens every profile in full.
Sign in